NCT04689581

Brief Summary

In this study, we compared ultrasound-guided modified pectoral nerve (PECS) block and bi level erector spinae plane (ESP) block on postoperative analgesic effect in breast surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable postoperative-pain

Timeline
Completed

Started Jan 2020

Typical duration for not_applicable postoperative-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

December 27, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 30, 2020

Completed
11 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2021

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2021

Completed
Last Updated

June 29, 2021

Status Verified

June 1, 2021

Enrollment Period

1 year

First QC Date

December 27, 2020

Last Update Submit

June 28, 2021

Conditions

Keywords

Regional anaesthesiaErector spinae plane blockPECs blocksBreast cancer surgery

Outcome Measures

Primary Outcomes (2)

  • Morphin consumption

    Patients in both groups will provide with intravenous patient-controlled analgesia device containing morphine for postoperative analgesia.

    during postoperative 24 hour

  • numerical rating scale (NRS)

    A numerical rating scale (NRS) requires the patient to rate their pain on a defined scale. For example, 0-10 where 0 is no pain and 10 is the worst pain imaginable

    during postoperative 24 hour

Study Arms (2)

Bi-level erector spinae plane block

EXPERIMENTAL

Bi-level ultrasound (US)-guided Erector spinae plane block (ESP) with 30 ml 0.25% bupivacaine at the T2 andT4 vertebral level will performe preoperatively to all patients in the ESP group.

Other: Ultrasound guided bi-level erector spinae plane block

Modified pectoral nerve block

EXPERIMENTAL

Ultrasound (US)-guided modified pectoral nerve block (PECs) with 30 ml 0.25% bupivacaine will performe preoperatively to all patients in the PECs group.

Other: Ultrasound guided modified pectoral nerve block

Interventions

Bi-level ultrasound (US)-guided Erector spinae plane block (ESP) with 30 ml 0.25% bupivacaine at the T2 andT4 vertebral level will performe preoperatively to all patients in the ESP group.

Bi-level erector spinae plane block

Ultrasound (US)-guided modified pectoral nerve block (PECs) with 30 ml 0.25% bupivacaine will performe preoperatively to all patients in the PECs group.

Modified pectoral nerve block

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesiologists Classification (ASA) I-II patients
  • aged patients
  • patients who scheuled elective breast cancer surgery

You may not qualify if:

  • American Society of Anesthesiologists Classification (ASA) III-IV patients
  • patients with coagulopathy
  • patients with infection at the injection site

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kocaeli University

Kocaeli, Turkey (Türkiye)

Location

Related Links

MeSH Terms

Conditions

Pain, PostoperativeAgnosia

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Study Officials

  • Sevim Cesur, MD

    Kocaeli University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
DR

Study Record Dates

First Submitted

December 27, 2020

First Posted

December 30, 2020

Study Start

January 1, 2020

Primary Completion

January 10, 2021

Study Completion

January 15, 2021

Last Updated

June 29, 2021

Record last verified: 2021-06

Locations